The Neostigmine Methylsulfate Injection Market Size is valued at USD 156.54 Mn in 2022 and is predicted to reach USD 228.43 Mn by the year 2031 at a 4.4% CAGR during the forecast period for 2023-2031. Neostigmine methylsulfate is a reversible cholinesterase inhibitor. Cholinesterases are enzymes responsible for breaking down the neurotransmitter acetylcholine at the neuromuscular junction. By inhibiting these enzymes, neostigmine allows acetyl...
Report ID: 2046 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 175
The Mini Bioreactors and Micro Bioreactors Market is expected to grow at a 11.0 % CAGR during the forecast period for 2023-2031. Traditional methods for growing microbial cells have lagged behind automated technologies based on arrays for manipulating DNA and uncovering biological systems. Systems that enable optimization, quick testing, and bioprocess development in low volume, parallel research with setup, and in a short amount of time are t...
Report ID: 1295 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 170
The Nano-Dentistry Market Size is valued at 835.0 Million in 2022 and is predicted to reach 2739.0 Million by the year 2031 at a 14.2% CAGR during the forecast period for 2023-2031. The use of nanotechnology in dentistry for the detection, treatment and prevention of oral and dental disease is known as nano dentistry. These methods are meant to improve and preserve oral health. Nanotechnology, biotechnology, counting tissue design, and eventua...
Report ID: 1315 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 175
The Single-use Upstream Bioprocessing Market is expected to grow at a 15.7 % CAGR during the forecast period for 2023-2031. The first step in the bioprocess is upstream bioprocessing, which is used to generate cell lines and cultivate them in order to grow the cells by harvesting. Modern cell growth techniques produce bioreactors with noticeably higher titers, shorter time constraints, and more precision. Upstream manufacturing's main objectiv...
Report ID: 1318 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Smart ICU Beds & Heads Market is expected to grow at a 5.5 % CAGR during the forecast period for 2023-2031. Smart beds are networked to give a variety of medical data, including personal data such as weight, body temperature, pulse, blood pressure, oxygen saturation, and other vital signs, medication, laboratory test results, allergies, and vaccination status. The increased need for state-of-the-art medical facilities, rising healthcar...
Report ID: 1324 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 185
The Proteome Profiling Services Market is expected to grow at an 11.5 % CAGR during the forecast period for 2023-2031. Proteome profiling refers to the high-throughput analysis of biological samples at a large scale for identifying, detecting, and functionalizing resident proteins, as proteins are complex biomolecules that involve various essential functions in living organisms. This process consists in studying polypeptide structure, function...
Report ID: 1346 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Infection Surveillance Solutions Market Size is valued at USD 544.93 Mn in 2022 and is predicted to reach USD 1581.37 Mn by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031. The term "infection surveillance solutions" refers to systems continuously tracking and managing information on healthcare-associated infections (HAIs) for public health evaluation. The effective implementation of preventative interventions depen...
Report ID: 1988 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Animal Placental Protein Market Size is valued at USD 527.09 Mn in 2022 and is predicted to reach USD 837.97 Mn by the year 2031 at a 5.5% CAGR during the forecast period for 2023-2031. Animal placental proteins refer to proteins that are obtained from the placentas of various animal species. The placenta is an organ that undergoes development during pregnancy in the majority of animal species, including humans. Its initial function is to ...
Report ID: 2022 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031. Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as al...
Report ID: 1059 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 170
The Fragile X Syndrome Market Size is valued at 20.80 Million in 2022 and is predicted to reach 37.71 Million by the year 2031 at a 7.0 % CAGR during the forecast period for 2023-2031. Fragile X syndrome is a hereditary condition that causes a range of neurological problems, including cognitive impairment and learning disabilities. Males are more affected compare to females by this disorder. It causes delayed development of speech and lang...
Report ID: 1065 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
Pharmaceuticals